INTRODUCTION
Malaria is known to be a complex and overwhelming health problem, with 300-500 million infections and 2 to 3 million deaths occurring each year. [1] [2] [3] About 90% of these deaths occur in sub-Saharan Africa. 1 Each year, about 25 to 30 million pregnant women living in malaria endemic areas of Africa are affected; with about 10,000 maternal mortalities and 200,000 new born deaths. [4] [5] Although often asymptomatic, especially in immune women, malaria has been implicated in several studies as a cause of some unfavourable pregnancy outcomes. [6] [7] [8] [9] These outcomes include anemia in pregnancy, fetal anemia, miscarriage, intra-uterine fetal death, premature labour and congenital malaria. The adverse consequences are mainly as a result of sequestration of parasitized erythrocytes present in the placental intervillous spaces, to chondroitin sulphate A (CSA) in the placenta.
This sequestration in the placenta is a virulence factor exclusively displayed by Plasmodium falciparum and not by other human malaria parasites. 13 The World Health Organization (WHO) has recommended a three prong approach to the prevention and control of malaria during pregnancy in areas of stable transmission through the use of intermittent preventive (IPT) of asymptomatic pregnant women, use of insecticide treated nets (ITNs) and prompt and effective case management of acute malaria in pregnancy. 14 Although there have been some studies demonstrating how placental parasitaemia adversely affect pregnancy outcome in some parts of the country, 6, 8, 9, 15 none has been conducted in Akwa Ibom State, South -South Nigeria. Considering the endemic nature of the disease in the State and the impact it could have on both mother and the fetus, this study was necessary to determine the prevalence of placental malaria and its influence on pregnancy outcome especially during the peri-partum period when preventive measures would have already been instituted. The findings of this study will assess the effects of the interventions in place and recommend strategies to tackle the problems of malaria in pregnancy not only in our environment, but in the country as a whole.
MATERIALS AND METHODS
Study Area: The study was carried out at the labour ward of the University of Uyo Teaching Hospital (UUTH), located in Uyo, the capital city of oil rich Akwa Ibom State, in the South-South geopolitical zone of Nigeria. Uyo is a malaria holo-endemic area located in the rain forest belt of Nigeria with a population of 3,902,051 people, of which 1,040,093 women are within the reproductive age group (2006 National Census figures). University of Uyo Teaching Hospital is the only tertiary health facility in the State and serves as a major referral centre for both government owned and privately owned maternity centers in Uyo and its environs. Antenatal clinics usually hold on Mondays, Tuesdays, Thursdays and Fridays while booking clinics hold Wednesday of every week. Apart from routine screening for hypertension, proteinuria and glycosuria, blood is usually taken for packed cell volume, (PCV), blood grouping, Rhesus typing and haemoglobin genotype. Voluntary counseling and testing for human immunodeficiency infection (HIV) is also usually carried out routinely. Also, attention is usually routinely paid to the prevention of anaemia and malaria using haematinics and intermittent preventive treatment (IPT) for malaria respectively.
Study population, recruitment and data collection
A systematic random sampling technique where every second parturient who booked for antenatal care in UUTH and presented in the labour ward for delivery, was used to recruit 330 consenting parturients into the study. Paturients who had obstetric or medical complications such as diabetes mellitus, hypertensive disorders of pregnancy, history of antepartum haemorrhage, sickle cell disease in pregnancy, and multiple pregnancy were excluded from the study. Information was obtained from respondents using an interviewer administered questionnaire.
Three (3ml) of blood was collected from the peripheral vein of each parturient into sample bottle containing Ethylene Diamine Tetra-Acetic Acid (EDTA), for a thick and thin film and also for estimation of PCV using standard laboratory procedures at the microbiology and side laboratories of the hospital. Test was carried out by certified medical laboratory scientists.
On completion of the third stage of labour and within 30minutes following the expulsion of the placenta, 3mls of blood was collected from umbilical cord and emptied into EDTA bottle for thick blood film for MP and PCV. Two millilitres of blood was also collected from the paramedian maternal surface of the placenta with a syringe, using aspiration method, 16 and emptied into an EDTA bottle for thick and thin blood films. The slides were labeled M, C, and P to represent maternal, cord and placental samples respectively for each subject before being transported to the microbiology laboratory for further processing and subsequent reading. A blood film was considered positive for malaria if malaria parasites were observed.
After delivery, the neonate's demographic and clinical characteristics were obtained and recorded on the questionnaire. Such data included: Gestational age at delivery, Apgar score at 5 minutes, and the birth weight of the baby in kilograms.
Packed cell volume estimation
Two non-heparinized capillary tubes for each subject, each with three-quarter of the tubes filled with blood taken from the 3 ml of peripheral blood already obtained by venepuncture, were sealed at the distal end with plasticin. A similar procedure was done for the cord blood samples already taken. Four capillary tubes containing blood samples were then sent to the laboratory where they were placed in a centrifuge and spun at 3000 revolutions per minute for 5 minutes to determine the PCV. The PCV was read with a Hawsley's Haematocrit Reader. The mean of two values of the packed cell volume for each subject was used.
Thick and thin blood films preparation and staining
A drop of blood from the maternal peripheral vein, the umbilical vein, and from the intervillous space of placenta respectively, was each placed on the middle portion of a clean, grease-free 76 mm x 25 mm microscope glass slide, with a thick and thin film prepared separately. The drop of blood on each of the slides was then dispersed to fill a large circle at the middle of the slide to make a thick blood film. The thin film was prepared in such a way that newsprint could be read through it. The various smears were then allowed to air dry. The thin blood smear was fixed in absolute methanol for about 5 seconds and thereafter, it was removed and placed vertically on the rack for 2-3 minutes. The dry slides of both thick and thin films were stained in a trough containing 3% Giemsa stain for 30 minutes. The slides were then removed with the aid of forceps and rinsed in buffer solution to maintain a pH of 7.2. The back of the slides was wiped dry and clean with the aid of dry cotton wool.
Reading of slides and parasite count
The slides were allowed to dry in atmospheric air before subjecting them to microscopic examination. The stained smears were examined under x 100 oil immersion lens of a binocular light microscope. Diagnosis of malaria was based on identification of any malaria parasite on the thick film while thin smears were used for species identification. Where malaria parasites were present, parasite density was estimated from the thick blood film by multiplying the average number of parasites per high power field (HPF) by a factor of 500 as proposed by Greenwood and Armstrong. 17 For this study, low birth weight was defined as birth weight less than 2.5 kg irrespective of the gestational age. Babies delivered between 37 completed weeks and 42 weeks of gestation were regarded as term babies while delivery before 37 completed weeks of gestation was regarded as preterm. A PCV of less than or equal to 33% was considered as anemia for parturients while a value of less than 38% was regarded as fetal anemia.
Sample size determination
The sample size was obtained using the formula, n= z 2 pq/d 2 , where n = minimum sample size, z = a value of standard normal deviation corresponding to 1.96, p = prevalence, q = 1 -p, and d = sampling error of 5%. The estimated sample size was calculated to be 297 using a previously reported prevalence of placental parasitaemia of 26.2%. 15 To allow for attrition rate of 10%, the minimum sample size required for this study was 327. However, 330 parturients were recruited.
Statistical analysis
Data obtained was analyzed with the statistical package for social sciences (SPSS) version 17 Inc. Chicago, Ilinois, USA and presented in tables and charts. The student t-test was employed to determine statistical difference between continuous variables while the chi-square test was used to compare proportions for categorical variables. Logistic regression was used to analyze factors associated with the main outcome variables. The level of statistical significance was taken as P≤ 0.05.
Ethical approval
Ethical approval to carry out the study was obtained from the Ethical Review Committee of the University of Uyo Teaching Hospital, Uyo. Informed consent was obtained from parturients. Participation was voluntary.
RESULTS
A total of 330 women participated in the study with a 100% response rate. The mean age of the respondents was 28.8 ± 4.4 years with a range of 17-42 years. The majority of respondents (63.3%) had tertiary education. A higher proportion were skilled workers (37.3%) and almost all (99.4%) were married (Table1).
The majority (96%) had term pregnancy with a mean gestational age of the subjects at time of delivery of 39.3 ± 1.5 weeks. Most (34.9%) were nulliparous, 7% were HIV positive and the prevalence of maternal malaria parasitaemia, cord parasitaemia and placental parasitaemia were 30.3%, 14.8% and 18.2% respectively. The mean packed cell volume was 34.0 ± 3% with majority (73%) having a PCV of > 33%. Seventeen (5.2%) of the neonates had low birth weight and almost all (96.7%) had an APGAR score of 7 or more at 5 minutes (Table 2) . M a l a r i a p r e v e n t i v e m e a s u r e s u s e d w e r e ITNs (70.9%), insecticides (78.8%), (sulphad oxine/pyrimethamine -intermittent preventive treatment for malaria (SP-IPT) > 2 doses (34.2%) and both ITNs and ≥ 2 doses of SP (20.6%) ( Table 3 ).
The proportion of women that used ITN and also took at least two doses of IPT was found to be similar among the 3 parity groups (Figure 1 ).
There was a significant positive linear association between placental parasitaemia and maternal parasitaemia (rho = 0.75; p < 0.001) and between placental parasitaemia and cord parasitaemia (rho = 0.87; p< 0.001), (Figures 2 and 3 ). Tere was no significant difference between placental parasitaemia and maternal anaemia when controlled for the other confounding variables for maternal anaemia (table4). While that of table 7 is -Also no association was found between placental parasitaemia and preterm delivery after adjusting for the effects of parity, maternal age, use of IPT and ITNs (Table 7) .
Placental parasitaemia was also significantly associated with fetal anemia and low birth weight, (Tables 5 and 6 ).
DISCUSSION
The prevalence of placental malaria in this study (18.2%) is similar to that (19.9%) reported by Tako, et al in Cameroon. 18 Higher rates of 33.2% and 53.6% were previously reported by Adebami et al 19 and BouyouAkotet et al 20 in Ile -Ife, Nigeria and Gabon respectively. The lower prevalence reported in this study may be due to the effective malaria control measures employed in the population, which include sulphadoxine -pyrimethamine 20 Several studies have shown that parity influences susceptibility to placental malaria with primigravidae being more susceptible compared to multigravidae. 19, 24, 25 In this study, higher parity did not confer any protection and this was consistent with the observations of Bako et al, 6 SuleOdu et al, 8 and Ofori et al. 24 This finding was not surprising as same proportion of women across the various parities (nulliparous, primiparous and multiparous) used ITNs and also had at least 2 doses of IPT.
Maternal malaria parasitaemia usually precedes placental malaria and this was further confirmed by the density of placental parasitaemia which positively correlated with that of maternal malaria parasitaemia. Similar findings have been reported by Bako et al 6 and Gilles et al 26 in Maiduguri and Burkina Faso respectively. Some of the mothers might have cleared the peripheral parasitaemia at the time of delivery mostly due to the use of IPT and case management of malaria in pregnancy and such mothers had negative malaria parasite even in the presence of placental parasitaemia.
Malaria has adverse effects on pregnancy outcome, causing maternal and fetal anaemia, low birth weight, intrauterine growth restriction, premature delivery, and still births. [6] [7] [8] [9] Various studies have linked placental malaria to maternal anaemia. 18, 24 However, in this study, there was no significant association between placental malaria and maternal anaemia when controlled for the other confounding variables, using the multivariate logistic regression model. This could be attributable to the fact that all the women in the study were booked and received antenatal care that included management of the risk factors for anaemia as well as correction of anaemia. For instance, almost all the women in the study (99.1%) received haematinics during the antenatal period. High parity and HIV positive status were identified as important risk factors for maternal anaemia in this study. This finding agrees with a study by Al-Farsi, et al where he found that anaemia in pregnancy was three times higher in high parity women compared with low parity pregnancies. 27 Also, van Eijk et al had found that HIV positivity is an important independent risk factor for anaemia in pregnancy. 28 Another complication of placental malaria is fetal anaemia which is thought to result from the exposure of the fetus to malaria antigens following the damage of the placental barrier.
The malaria antigens will induce immunologically mediated hemolysis or dyserythropoiesis. 29 In the logistic regression analysis model for factors associated with fetal anaemia, this study showed a statistically significant relationship between placental malaria and fetal anaemia. Similar finding has been reported by Brabin et al. 30 Non use of ITNs was found to be significant independent risk factor for fetal anaemia in this study (P = 0.01) This is due to increased risk of placental parasitaemia associated with non-use of ITNs. 23 Placental malaria was significantly associated with low birth weight in this study. The malaria parasites either directly cause mechanical compromise of placental circulation via widespread trophoblast membrane thickening, increased fibrinoid necrosis and cytotrophoblast prominence or indirectly interfere with placental function and induce pathological lesions. 31 The finding in this study agrees with those of Bako et al, 6 Okoko et al, 24 and Tako et al 18 .
Malaria-infected placentas frequently carry antibodies, cytokines and macrophages which are indicative of an active immune response and these go on to stimulate early labour. 32 Although some studies have shown an association between increased risk of preterm delivery with placental parasitaemia, 33,34 the association was not statistically significant in this study. This is similar to the findings of Bako et al 6 and Tako et al. 18 In conclusion, malaria in pregnancy is still a public health problem in Akwa Ibom State. The prevalence of maternal malaria and placental malaria of 30.3% and 18.2%, respectively, among pregnant women at delivery in UUTH, is alarming and calls for concern as malaria in pregnancy is known to have adverse pregnancy outcomes. The relatively high prevalence in this study despite the various malaria preventive measures that were instituted during the antenatal period, underlines the need for more attention to be focused on easily preventable diseases such as malaria and HIV infection.
Placental malaria is associated with low birth weight, cord parasitaemia, fetal anaemia, and lower mean maternal packed cell volume. HIV sero-positivity and low ITNs usage are risk factors for fetal anaemia. The use of ITNs, IPT and adequate treatment of malaria during pregnancy and prophylaxis against anaemia with haematinics, can significantly protect against placental malaria and its sequelae.
